Global Recombinant Cell Culture Supplements Markets, 2019-2029: Rising Demand for Monoclonal Antibodies and Stem Cell ResearchHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Global Recombinant Cell Culture Supplements Markets, 2019-2029: Rising Demand for Monoclonal Antibodies and Stem Cell ResearchPR NewswireJanuary 3, 2020ReblogShareTweetShareDUBLIN, Jan. 3, 2020 /PRNewswire/ -- The "Global Recombinant Cell Culture Supplements Market: Focus on Product Type, Applications, 5 Regional Data, 23 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029" report has been added to ResearchAndMarkets.com's offering.Research and Markets LogoMoreAccording to the report, the global recombinant cell culture supplements market was valued at $258.8 million in 2018 and is anticipated to grow over $977.8 million by 2029. The global recombinant cell culture supplements market is expected to grow at CAGR of forecast period 2019-2029, aided primarily by the increased use of cell culture technology for research, production, and stem cell and regenerative medicine therapy.This report provides a holistic view of the market in terms of various factors influencing it, including product optimization, and technological advancements.The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the market. In addition, the study also includes exhaustive information on the unmet needs, perception of the new products, competitive landscape, market share of leading manufacturers, the growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global recombinant cell culture supplements market.Cell culture is a major process in the biotechnological field for the modern-day life sciences. As the use of cell cultures has increased in the current scenario, the market offers great potential for growth and presents a million-dollar opportunity. Prominent players of cell culture media and supplement market include Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Hi-Media Laboratories, Sartorius AG, InVitro, SeraCare Life Sciences, Inc., GE Healthcare, Novozymes A/S, and Advanced Biotechnologies, Inc., among others.North America is the leading contributor in the recombinant cell culture supplements market and contributed approximately 38.0% to the global market value in 2018. This region is anticipated to grow significantly during the forecast period from 2019 to 2029 and continue to dominate the global market in 2029. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. The Europe region also contributed a significant share of 25.5% to the global market.Research HighlightsRecombinant Epidermal growth factor is expected to witness a robust CAGR of 16.29% during the forecast period 2019-2029. However, the recombinant albumin market is anticipated to dominate during the forecast period 2019-2029. Merck KGaA is currently the largest shareholder in the global recombinant cell culture supplements market. This market dominance is attributed to the broad range of recombinant cell culture supplements product portfolio that it is offering in this market and the massive demand for the company's product lines.Key Questions Answered in the ReportWhat is the role of media and supplements in cell culture and what are the advantages associated with serum-free media? What is the importance of recombinant proteins in cell culture applications? What are the key trends of the global recombinant cell culture supplements market? How is the market evolving and what is its future scope? What are the major drivers, challenges, and opportunities of the global recombinant cell culture supplements market? What are the key developmental strategies implemented by the key players of the global recombinant cell culture supplements to sustain the competition of the market? What is the percentage share of each of the key players in different key developmental strategies? What is the regulatory scenario of the global recombinant cell culture supplements market? What are the initiatives implemented by different governmental bodies and guidelines put forward to regulate the commercialization of recombinant cell culture supplements products? What was the market size of the global recombinant cell culture supplements market in 2018 and what is the market size anticipated to be in 2029? What is the expected growth rate of the global recombinant cell culture supplements market during the period between 2019 and 2029? What are the different recombinant supplement products involved in cell culture? Which product type dominates the market in 2018 and why? Which product type is expected to witness the highest growth rate and to dominate in the market in 2029? What are the different application areas of the global recombinant cell culture supplements market? Which application type dominates the market in 2018 and is expected to dominate in 2029? What was the market value of the leading segments and sub-segments of the global recombinant cell culture supplements market? What are the different macro and micro factors influencing the growth of the market? Which region is expected to contribute the highest sales of the global recombinant cell culture supplements market during the period between 2018 and 2029? Which region and country carries the potential for the significant expansion of key companies for different recombinant cell culture supplement products? What are the leading countries of different regions that contribute significantly toward the growth of the recombinant cell culture supplements market? What are the key players of the global recombinant cell culture supplements market and what is their role in the market?Key Topics CoveredExecutive Summary1 Scope of the Work1.1 Overview: Report Scope1.2 Segmentation of the Global Recombinant Cell Culture Supplements Market1.3 Assumptions and Limitations1.4 Key Questions Answered in the Report1.5 Base Year and Forecast Period2 Research Methodology2.1 Overview: Report Methodology3 Market Overview3.1 Fundamentals of Cell Culture3.2 Role of Media and Supplements3.3 Serum-free Media vs. Serum containing Media3.4 Technological Advancements of Defined Media and the Importance of Recombinant Cell Culture Supplements3.5 Recombinant Cell Culture Supplements Market Scenario3.6 Assumptions and Limitations for Market Size Calculations4 Market Dynamics4.1 Impact Analysis4.2 Market Drivers4.2.1 Benefits of Using Recombinant Cell Culture Supplements4.2.2 Increase in Funding and Investment in R&D of Life Science Sector4.2.3 Rising Demand for Advanced Cell Culture Products4.3 Market Restraints4.3.1 High Cost of Cell Biology Research4.3.2 Technical Considerations Associated with Cell Culture4.3.3 Lack of Infrastructure and Skilled Professionals for Cell-based Research4.4 Market Opportunities4.4.1 Rising Demand for Monoclonal Antibodies and Stem Cell Research4.4.2 Increasing Preference for Serum-Free Media5 Industry Insights5.1 Regulatory Scenario5.2 Patent Landscape6 Competitive Landscape6.1 Overview6.2 Key Developments and Strategies6.2.1 Product Launch and Development6.2.2 Collaborations, Partnerships, and Joint Ventures6.2.3 Acquisitions6.2.4 Business Expansions6.2.5 Others6.3 Market Share Analysis6.4 Growth Share Analysis7 Global Recombinant Cell Culture Supplements Market (by Products)7.1 Overview7.2 Recombinant Albumin (rAlbumin)7.3 Recombinant Insulin (rInsulin)7.4 Recombinant Epidermal Growth Factor (rEGF)7.5 Recombinant Transferrin (rTransferrin)7.6 Recombinant Trypsin (rTrypsin)7.7 Recombinant Insulin-like Growth Factor (rIGF)7.8 Recombinant Stem Cell Factor Protein (rSCF)7.9 Recombinant Aprotinin (rAprotinin)7.10 Recombinant Lysozyme (rLysozyme)7.11 Others8 Global Recombinant Cell Culture Supplements Market (by Application)8.1 Overview8.2 Stem Cell and Regenerative Medicine8.2.1 Stem Cell Therapy8.2.2 Cell Therapy8.2.3 Gene Therapy8.3 Bioproduction8.3.1 Monoclonal Antibodies8.3.2 Recombinant Proteins8.3.3 Vaccines8.3.4 Hormones8.3.5 Other Biological Products8.4 Academic and Research Application9 Global Recombinant Cell Culture Supplements Market (by Region)9.1 Overview9.2 North America9.3 Europe9.4 Asia-Pacific9.5 Latin America9.6 Rest-of-the-World10 Company Profiles10.1 Overview10.2 BBI Solutions10.3 Corning Incorporated10.4 Evercyte GmbH10.5 FUJIFILM Irvine Scientific10.6 Gemini Bio-Products10.7 HiMedia Laboratories10.8 InVitria10.9 Kingfisher Biotech, Inc.10.10 Lonza Group AG10.11 Merck KGaA10.12 PeproTech, Inc.10.13 Shenandoah Biotechnology10.14 Sino Biological Inc.10.15 STEMCELL Technologies Inc.10.16 Thermo Fisher Scientific Inc.For more information about this report visit https://www.researchandmarkets.com/r/4hm3b5Story continuesResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.Media Contact:Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716CisionMoreView original content:http://www.prnewswire.com/news-releases/global-recombinant-cell-culture-supplements-markets-2019-2029-rising-demand-for-monoclonal-antibodies-and-stem-cell-research-300980846.htmlSOURCE Research and MarketsReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextLatin America roundup: SoftBank adds $1B, Stori raises $10M and Grow Mobility puts on the brakesTechCrunch4 Giants See Stocks Plummet on Coronavirus WarningsGuruFocus.comTrade Desk Tops Earnings Views, Sets Higher Investments In Internet TVInvestor's Business DailyWalmart’s Answer to Amazon Prime? Walmart+Footwear NewsBudweiser Brewer Shares Dive as It Loses More U.S. Market ShareThe Wall Street JournalRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo Finance